
Opinion|Videos|July 8, 2024
Hidradenitis Suppurativa: Addressing the Psychosocial Impact and Hospitalization Rate
Author(s)Iltefat Hamzavi, MD
Dr Hamzavi discusses how clinicians can address the psychosocial impact of hidradenitis suppurativa on patients and the rate of hospitalization.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the psychosocial impact of HS and how can clinicians empower these patients?
- How is the rate of hospitalization due to HS changing over time and what can clinicians do to keep patients out of the hospital?
- How is the rate of hospitalization due to HS changing over time and what can clinicians do to keep patients out of the hospital?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Eliminating Cost Sharing Boosted Follow-Up Colonoscopy Rates
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5















































